Avanos Medical (AVNS) Treasury Shares (2015 - 2026)

Avanos Medical (AVNS) has 12 years of Treasury Shares data on file, last reported at $103.6 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 2.37% year-over-year to $103.6 million; the trailing twelve-month figure through Mar 2026 stood at $103.6 million (up 2.37% YoY), and the FY2025 full-year result was $102.3 million, up 3.33% from the prior year.
• Treasury Shares grew to $103.6 million in Q1 2026, from $102.3 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $3.9 million in Q4 2025 to a low of $451965.0 in Q3 2023.
• A 5-year average of $1.7 million and a median of $1.1 million in 2024 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares soared 538.46% in 2022 and advanced 2.37% in 2026, its largest moves.
• Tracing AVNS's Treasury Shares over 5 years: stood at $66.8 million in 2022, then advanced by 28.59% to $85.9 million in 2023, then rose by 15.25% to $99.0 million in 2024, then increased by 3.33% to $102.3 million in 2025, then advanced by 1.27% to $103.6 million in 2026.
• Business Quant data shows AVNS's Treasury Shares at $103.6 million in Q1 2026, $102.3 million in Q4 2025, and $102.0 million in Q3 2025.